A medical expert warned of the side effects of the newly launched weight loss drug Ozempic.

Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, ...

New Delhi, 13 Dec 2025 (ANI): Novo Nordisk launches Ozempic in India for diabetes, weight management at ₹2,200/week ...

“Sensitive to Indian socioeconomic class”, Novo Nordisk MD on introducing Ozempic at ₹2,200 per week ...

As India grapples with a growing burden of diabetes and lifestyle-related disorders, attention has turned to Ozempic, a globally used diabetes medication recently launched in India by Novo Nordisk.

Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...

After two successful years, NOVO's third annual concert will take place on Sunday, Dec. 14 at 2:30 p.m. at the Powerhouse Theatre (2901 35th Ave).

Emirates could produce all its protein needs, says Burnbrae Group chairman ...